Study Published in Science Translational Medicine Reports Favorable Safety and Extended Survival for Brain Cancer Patients Treated with Tocagen’s Cancer-Selective Viral Gene Therapy
This is impressive results from a small study. There is a large multicenter trial going on now for recurrent high grade glioma and they will soon start one for newly diagnosed.
And they acknowledge the Musella Foundation (and other brain tumor foundation) grant support for this project! This is your generous donations at work!
IF the story does not appear below, Click HERE to view the text of the story!
Note: The original website is displayed below - we have no control over it and are not responsible for the content of it, we just report it! IF you click on anything below, it will take you off of our website!
Original Source: http://tocagen.com/study-published-science-translational-medicine-reports-favorable-safety-extended-survival-brain-cancer-patients-treated-tocagens-cancer-selective-viral-gene-therapy/
(Everything below this line is from VirtualTrials.com!)
Click HERE to return to brain tumor news headlines